RSS

RMTG Regenerative Medical Technology Group Inc.

Last Post: 07/28/26
Followers: 57
Posts Today: 0
Views Today: 3126

RMTG Stock Quote & Tools

$0.0450 ▲ +0.0050 (+12.50%) As of Oct 27, 12:00 PM EDT
Last0.0450
$ Chg0.0050
Open0.0400
High0.0450
Beta0.5086
Year High0.125
Market Cap618.3K
P/B Ratio-0.02
EPS-0.75
Avg Vol (30d)37.8K
Volume10.2K
% Chg+12.50%
Prev Close0.0400
Low0.0400
VWAP0.04010
Year Low0.019
Total Shares13.74M
Shares Out13.74M
Float12.41M
ExchangeOTCID
Healthcare Biotechnology & Life Sciences

RMTG Stock Message Board Discussion

  1. JAVA1
  2. JAVA1

Top 10 Most Recent News Articles

HOST's $50M Boost Fuels Avondale's Expansion

Updated Category News Views 69

Big Bucks for Avondale's Next Leap HOST isn't playing around with pocket change here. The company's coughing up a neat $50 million to propel Avondale Global Gateway into its next chapter. This investment means serious business—it’s cranking up capacity like a power plant on overdrive, laying down more rail, warehouse spaces, and dock improvements. A new...

Continue Reading
FirstEnergy's New Tech to Bolster Pennsylvania Grid

Updated Category News Views 0

Electricity Demand Spurs Grid Innovation The winds of change are blowing across Pennsylvania's power grid. FirstEnergy Transmission's (NYSE:FE) subsidiary, Keystone Appalachian Transmission Company (KATCo), is diving into a significant federally funded project to reinforce grid reliability. With electricity demand on an upward trajectory, Pennsylvania and beyond need...

Continue Reading
AppGate Rises as 2026 Leader in Digital Risk

Updated Category News Views 67

AppGate: Forging a Path in Digital Security In a world where cyber threats seem to lurk around every digital corner, snagging the title of a leader in digital risk protection from the SPARK Matrix is no small feat. Let’s dive deep into AppGate’s rise to the top in QKS Group’s 2026 evaluation. What Sets AppGate Apart? AppGate's leadership status isn't some overnight...

Continue Reading
New Research Awards Target Drug Resistance in Cancers

Updated Category News Views 68

Well, this is a breath of fresh air in the lung cancer scene, let's talk about some promising news for those battling RET-positive cancers. The LUNGevity Foundation and RETpositive have handed out some well-deserved awards to researchers aiming to crack the stubborn nut of drug resistance in RET-positive cancer therapies. Changing the Game for RET-positive Cancer RET gene...

Continue Reading
Nektar Therapeutics Gears Up for Q3 Financial Reveal

Updated Category News Views 56

Anticipation Builds as Nektar Preps Financial Report Ah, the life of a biotech investor, riding high or gripping the rail as tides turn with every quarterly report. This time, we're turning our gaze to Nektar Therapeutics and their Q3 financial results slated for release on November 12th, just as the market dust starts settling for the day. Now, if you’re wired to...

Continue Reading
HDF and IOM Join Forces for Crisis Relief Efforts

Updated Category News Views 62

New Partnership Navigates Humanitarian Complexities Alright, let's cut to the chase. Today, HDF and IOM threw another log on the fire powering humanitarian aid. These big names just inked a Memorandum of Understanding in Geneva, emphasizing their goal of streamlined cooperation to counter crises in Sudan and Yemen. Now, if you're curious about the weight of such...

Continue Reading
Heart Failure Certification Highlights Quality at Two Centers

Updated Category News Views 26

Celebrating Milestones in Healthcare Certification Out there in the Bronx, two skilled nursing facilities just snagged a certification that means they're playing in the big leagues of heart failure care. Holliswood Center and Bushwick Center, both under the Centers Health Care umbrella, have been awarded the Skilled Nursing Facility Heart Failure Certification from none...

Continue Reading
Heart Attack vs. Cardiac Arrest: Know the Differences

Updated Category News Views 91

Spotting the Crisis: Heart Attack or Cardiac Arrest? When your heart’s in trouble, knowing whether it’s a heart attack or cardiac arrest isn’t just some medical trivia—it could save a life. According to healthcare whiz Justin Doss from Beaumont, Texas, this difference can be the thin line between life and a dire outcome. What's the Deal with These Heart Events?...

Continue Reading
Travelers Juggle Cash and Cards Abroad: Survey Insights

Updated Category News Views 0

Travel Spending: Balancing Convenience with Costs Navigating the financial landscape when you're a traveler abroad ain't always a walk in the park, folks. A fresh survey by Upgraded Points takes a gritty dive into how 1,500 globe-trotters juggle cash and cards while hopping across borders. The nitty-gritty? Messy exchange rates, sneaky fees, and the dreaded declined...

Continue Reading
Jamaica's Tourism Rebounds Post-Hurricane Challenges

Updated Category News Views 80

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Continue Reading

Top 5 Most Recently Viewed Articles

Federal Realty's Upcoming Earnings Call: Essential Details Inside

Updated Category News Views 162

Federal Realty Investment Trust's Upcoming Earnings Call Federal Realty Investment Trust, recognized for its excellence in the retail real estate sector, is gearing up to announce its third quarter earnings results. This momentous occasion will take place before the market opens, specifically on a Friday in late October. The investors and interested parties can look...

Continue Reading
Revolutionizing Cancer Treatment: Insights from Molecular Partners

Updated Category News Views 187

Exciting Developments in Cancer Therapy Molecular Partners AG, a pioneering clinical-stage biotech company, is reshaping the landscape of cancer treatment with their innovative approach to protein drug development. Known for their unique DARPin therapeutics, they are presenting groundbreaking research on the logic-gated CD3 Switch-DARPin T cell engager at a prominent...

Continue Reading
Equifax Sets Date for Q3 2025 Earnings Call and Release

Updated Category News Views 218

Equifax Announces Q3 2025 Results Timeline Equifax Inc. (NYSE: EFX) is gearing up to announce its financial results for the third quarter, which ended on September 30, 2025. The company plans to release this information on an upcoming Tuesday morning, precisely at 6:30 a.m. Eastern Time (ET). Details of the Earnings Call Following the earnings release, Equifax will...

Continue Reading
Innovative Study on Omega-3 DHA Foods and Public Health

Updated Category News Views 221

New Study Revolutionizes Omega-3 DHA Foods in Public Health A remarkable breakthrough in public health emerges with the unveiling of findings from a pivotal Human Nutritional Intervention Study. This study, overseen by a prominent university, involved collaboration with leading institutions and producers who are dedicated to elevating nutritional standards through...

Continue Reading
Monarch Casino & Resort Set to Release Q1 2025 Results Soon

Updated Category News Views 264

Monarch Casino & Resort to Announce First Quarter Results Monarch Casino & Resort, Inc. (NASDAQ: MCRI), a prominent player in the entertainment industry, has recently shared important news regarding its upcoming financial report. The company is set to publish its financial results for the first quarter of 2025 after the market closes on April 22. Investors and...

Continue Reading